Merck & Co Inc
NYSE:MRK
Merck & Co Inc
NYSE:MRK
Price:
116.74
USD
0.82%
Market Cap:
$289.8B
Relative Value
The Relative Value of one
MRK
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 116.74 USD,
Merck & Co Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MRK Relative Value
HIDDEN
Multiples Across Competitors
MRK Competitors Multiples
Merck & Co Inc Competitors
Merck & Co Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.2B USD | 4.4 | 15.8 | 9.8 | 12 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
940.1B USD | 14.5 | 45.9 | 30.9 | 33 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.4B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
262.5B CHF | 4.3 | 20.4 | 12 | 13.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
238.2B CHF | 5.5 | 22.1 | 13.7 | 17.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP | 5.1 | 29.3 | 16.2 | 22.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.3B USD | 2.5 | 17.2 | 7.2 | 8.9 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
83.2B GBP | 2.5 | 14.5 | 7.4 | 10.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
